Routine hepatitis B immunisation in India: cost-effectiveness assessment.
No Thumbnail Available
Date
2000-04-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.
Description
Keywords
Citation
Miller MA, Kane M. Routine hepatitis B immunisation in India: cost-effectiveness assessment. Indian Journal of Pediatrics. 2000 Apr; 67(4): 299-300